These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 35146812)
1. In vivo electrophysiological study of the targeting of 5-HT Schweimer JV; Brouard JT; Li Y; Sánchez C; Sharp T Eur J Neurosci; 2022 Mar; 55(6):1409-1423. PubMed ID: 35146812 [TBL] [Abstract][Full Text] [Related]
2. Involvement of 5-HT3 receptors in the action of vortioxetine in rat brain: Focus on glutamatergic and GABAergic neurotransmission. Riga MS; Sánchez C; Celada P; Artigas F Neuropharmacology; 2016 Sep; 108():73-81. PubMed ID: 27106166 [TBL] [Abstract][Full Text] [Related]
3. The multimodal antidepressant vortioxetine may facilitate pyramidal cell firing by inhibition of 5-HT Dale E; Grunnet M; Pehrson AL; Frederiksen K; Larsen PH; Nielsen J; Stensbøl TB; Ebert B; Yin H; Lu D; Liu H; Jensen TN; Yang CR; Sanchez C Brain Res; 2018 Jun; 1689():1-11. PubMed ID: 29274875 [TBL] [Abstract][Full Text] [Related]
4. Differentiated effects of the multimodal antidepressant vortioxetine on sleep architecture: Part 2, pharmacological interactions in rodents suggest a role of serotonin-3 receptor antagonism. Leiser SC; Iglesias-Bregna D; Westrich L; Pehrson AL; Sanchez C J Psychopharmacol; 2015 Oct; 29(10):1092-105. PubMed ID: 26174134 [TBL] [Abstract][Full Text] [Related]
5. The rapid recovery of 5-HT cell firing induced by the antidepressant vortioxetine involves 5-HT(3) receptor antagonism. Bétry C; Pehrson AL; Etiévant A; Ebert B; Sánchez C; Haddjeri N Int J Neuropsychopharmacol; 2013 Jun; 16(5):1115-27. PubMed ID: 23089374 [TBL] [Abstract][Full Text] [Related]
6. Regional distribution of serotonergic receptors: a systems neuroscience perspective on the downstream effects of the multimodal-acting antidepressant vortioxetine on excitatory and inhibitory neurotransmission. Pehrson AL; Jeyarajah T; Sanchez C CNS Spectr; 2016 Apr; 21(2):162-83. PubMed ID: 26250622 [TBL] [Abstract][Full Text] [Related]
7. Multimodal antidepressant vortioxetine increases frontal cortical oscillations unlike escitalopram and duloxetine--a quantitative EEG study in rats. Leiser SC; Pehrson AL; Robichaud PJ; Sanchez C Br J Pharmacol; 2014 Sep; 171(18):4255-72. PubMed ID: 24846338 [TBL] [Abstract][Full Text] [Related]
8. Effect of the multimodal acting antidepressant vortioxetine on rat hippocampal plasticity and recognition memory. Bétry C; Etiévant A; Pehrson A; Sánchez C; Haddjeri N Prog Neuropsychopharmacol Biol Psychiatry; 2015 Apr; 58():38-46. PubMed ID: 25524057 [TBL] [Abstract][Full Text] [Related]
9. Subchronic vortioxetine treatment -but not escitalopram- enhances pyramidal neuron activity in the rat prefrontal cortex. Riga MS; Teruel-Martí V; Sánchez C; Celada P; Artigas F Neuropharmacology; 2017 Feb; 113(Pt A):148-155. PubMed ID: 27671324 [TBL] [Abstract][Full Text] [Related]
10. Vortioxetine Subchronically Activates Serotonergic Transmission via Desensitization of Serotonin 5-HT Okada M; Okubo R; Fukuyama K Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31835640 [TBL] [Abstract][Full Text] [Related]
11. Vortioxetine dose-dependently reverses 5-HT depletion-induced deficits in spatial working and object recognition memory: a potential role for 5-HT1A receptor agonism and 5-HT3 receptor antagonism. du Jardin KG; Jensen JB; Sanchez C; Pehrson AL Eur Neuropsychopharmacol; 2014 Jan; 24(1):160-71. PubMed ID: 23916504 [TBL] [Abstract][Full Text] [Related]
12. Vortioxetine disinhibits pyramidal cell function and enhances synaptic plasticity in the rat hippocampus. Dale E; Zhang H; Leiser SC; Xiao Y; Lu D; Yang CR; Plath N; Sanchez C J Psychopharmacol; 2014 Oct; 28(10):891-902. PubMed ID: 25122043 [TBL] [Abstract][Full Text] [Related]
13. Sub-chronic vortioxetine (but not escitalopram) normalizes brain rhythm alterations and memory deficits induced by serotonin depletion in rats. Riga MS; Sanchez C; Celada P; Artigas F Neuropharmacology; 2020 Nov; 178():108238. PubMed ID: 32750446 [TBL] [Abstract][Full Text] [Related]
14. Vortioxetine, a novel antidepressant with multimodal activity: review of preclinical and clinical data. Sanchez C; Asin KE; Artigas F Pharmacol Ther; 2015 Jan; 145():43-57. PubMed ID: 25016186 [TBL] [Abstract][Full Text] [Related]
15. Effects of acute and sustained administration of vortioxetine on the serotonin system in the hippocampus: electrophysiological studies in the rat brain. El Mansari M; Lecours M; Blier P Psychopharmacology (Berl); 2015 Jul; 232(13):2343-52. PubMed ID: 25665528 [TBL] [Abstract][Full Text] [Related]
17. Lu AA21004, a novel multimodal antidepressant, produces regionally selective increases of multiple neurotransmitters--a rat microdialysis and electrophysiology study. Pehrson AL; Cremers T; Bétry C; van der Hart MG; Jørgensen L; Madsen M; Haddjeri N; Ebert B; Sanchez C Eur Neuropsychopharmacol; 2013 Feb; 23(2):133-45. PubMed ID: 22612991 [TBL] [Abstract][Full Text] [Related]
18. A 5-HT3 receptor antagonist potentiates the behavioral, neurochemical and electrophysiological actions of an SSRI antidepressant. Bétry C; Overstreet D; Haddjeri N; Pehrson AL; Bundgaard C; Sanchez C; Mørk A Pharmacol Biochem Behav; 2015 Apr; 131():136-42. PubMed ID: 25697477 [TBL] [Abstract][Full Text] [Related]
19. Modes and nodes explain the mechanism of action of vortioxetine, a multimodal agent (MMA): blocking 5HT3 receptors enhances release of serotonin, norepinephrine, and acetylcholine. Stahl SM CNS Spectr; 2015 Oct; 20(5):455-9. PubMed ID: 26122791 [TBL] [Abstract][Full Text] [Related]
20. Impact of Vortioxetine on Synaptic Integration in Prefrontal-Subcortical Circuits: Comparisons with Escitalopram. Chakroborty S; Geisbush TR; Dale E; Pehrson AL; Sánchez C; West AR Front Pharmacol; 2017; 8():764. PubMed ID: 29123483 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]